NCT00060255View on ClinicalTrials.gov

High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors

PHASE2CompletedINTERVENTIONAL
Enrollment

451

Participants

Timeline

Start Date

December 31, 1991

Primary Completion Date

August 31, 2006

Study Completion Date

February 28, 2013

Conditions
Breast CancerLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmTesticular Germ Cell TumorUnspecified Adult Solid Tumor, Protocol SpecificUnspecified Childhood Solid Tumor, Protocol Specific
Interventions
DRUG

busulfan

iv

DRUG

carboplatin

iv

DRUG

carmustine

iv

DRUG

cyclophosphamide

iv

DRUG

etoposide

iv

DRUG

melphalan

oral

DRUG

thiotepa

iv

PROCEDURE

autologous bone marrow transplantation

iv

PROCEDURE

bone marrow ablation with stem cell support

iv

PROCEDURE

peripheral blood stem cell transplantation

iv

RADIATION

radiation therapy

body x-ray

Trial Locations (1)

14263-0001

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER

NCT00060255 - High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors | Biotech Hunter | Biotech Hunter